The Saudi Arabia diabetes drugs market reached USD 829.6 million in 2024 and is projected to grow to USD 1,687.4 million by 2033, with a CAGR of 8.21% from 2025 to 2033. Market growth is driven by the rising prevalence of diabetes, increased adoption of innovative medications, and government healthcare initiatives. https://www.imarcgroup.com/saudi-arabia-diabetes-drugs-market